On Tuesday, the CME Coalition was featured in an article by Policy and Medicine for its participation in the May 9-10 Food and Drug Administration (FDA) public meeting on the training of healthcare providers on pain management and safe use of opioid medication. CME Coalition’s Andrew Rosenberg and Tom Sullivan provided comments at the meeting to reinforce that education is a valuable tool in combating the opioid epidemic. “To encourage clinician's to participate in the Opioid REMS, the CME Coalition recommended that FDA work with CMS to include Opioid REMS CME as an improvement activity in the Quality Payment Program,” the article notes. The piece also goes onto acknowledge the value and importance of continuing medical education as an asset in reducing overdose deaths due to opioids.
CME Coalition Statement on Passage of 21st Century Cures Act, Maintenance of Open Payments Reporting Exemption for Independent, Indirect CME Payments
FOR IMMEDIATE RELEASE
Contact: Andrew Rosenberg, (202) 247-6301
December 8, 2016 – On Tuesday, December 6, the Senate approved, by a vote of 94-5, a wide-ranging biomedical innovation bill called the 21st Century Cures Act (H.R. 34), which will provide about $4.8 billion over 10 years in medical research funding, make changes to the FDA’s review of medical products, and advance mental health reforms. The bill now heads to the desk of President Obama, who is expected to sign the measure into law. The bill passed the House of Representatives last week.
An article published in Policy and Medicine shows that since the release of Open Payments data, the percentage of physicians who do not allow access to medical industry salespeople have begun to increase. However, author Tom Sullivan argues that the increasing no-access rate might not be very beneficial for physicians. "Such high rates of no-access may not be the best thing for the health care industry as a whole" he writes. "Such visits from drug and device reps can be beneficial to doctors and their staff, as it provides a time for them to ask questions of the rep to see if the offered device or prescription is a good fit for any of their patients."
Yesterday, the CME Coalition was featured in an article by the Coalition for Healthcare Communication (CHC) on the Centers for Medicare and Medicaid Services' (CMS) recently revised FAQ post on its Open Payments website regarding the reporting of CME-related payments. The CME Coalition states that although “this FAQ is fully consistent with its earlier interpretation of the status of independent CME-related payments when CMS revised the regulations in 2014, as well as the interpretation of other leading stakeholders like the American Medical Association, the revised FAQ now provides even greater clarity to stakeholders.”
Today, Stat News published an article describing the fact that a number of national and state medical societies, including the American Medical Association and American College of Cardiology, are backing a Senate bill that would exempt drug and device makers from reporting payments made to doctors for receiving continuing medical education, or CME, sessions, medical journals, or textbooks. The article highlights the controversial nature of when Open Payments, the federal database which tracks financial relationships between companies and physicians, was launched in 2014 and goes on to outline a number of arguments these medical societies set forth in a letter to the bill's sponsor, Sen. John Barrasso (R-WY). “Passage of this bill is urgently needed to remedy onerous and burdensome reporting obligations imposed by CMS that have already chilled the dissemination of medical textbooks and peer-reviewed medical reprints and journals, and to avert a similar negative impact on access to independent” CME, the group writes.
Today, Modern Healthcare highlighted the fact that over 100 national and state medical societies are backing legislation that exempts drug and device makers from having to report payments made to doctors for participating in continuing medical education (CME) or receiving textbooks, journals and educational materials related to CME. The article highlights a group letter sent to Sen. John Barrasso (R-WY), sponsor of the bill, applauding him for his efforts. “This legislation would ensure that efforts to promote transparency do not undermine efforts to provide the most up-to-date independent medical knowledge, which improves the quality of care patients receive,” the letter reads.